U.S. market Closed. Opens in 28 minutes

NUTX | Nutex Health, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Revenue247.65M219.29M331.53M273.42M97.06M91.37K
Cost of Revenue212.87M205.84M152.25M1.82M1.66M62.30K
Gross Profit34.77M13.45M179.28M271.60M95.40M29.07K
Operating Expenses36.07M18.03M5.46M121.09M62.35M1.80M
Selling, General & Admin36.07M18.03M5.46M115.13M59.87M1.16M
Research & DevelopmentN/AN/A285.88K557.26K768.10KN/A
Other Operating Expenses-399.18K-559.30K5.42M5.96M2.48M633.57K
Operating Income-1.29M-5.14M170.26M152.33M34.71M-1.83M
Other Expenses / Income-47.20M-414.51M-773.88K-6.78M-2.62M-983.68K
Before Tax Income-48.49M-419.65M169.49M145.56M32.09M-2.81M
Income Tax Expenses-5.07M13.09M965.73K50.83M15.61MN/A
Net Income-45.79M-432.74M132.59M105.97M16.48M-2.81M
Interest Expenses16.32M12.49M6.20M6.43M3.53M-642.07K
Basic Shares Outstanding43.61M42.27M40.18M42.92M41.40M143.68M
Diluted Shares Outstanding44.08M42.33M39.52M42.92M41.40M143.68M
EBITDA16.30M7.99M186.90M157.95M38.10M-1.83M
EBITDA Margin6.58%3.65%56.38%57.77%39.25%-2,003.39%
EBIT-34.54M-407.16M139.76M163.24M35.62M-3.46M
EBIT Margin-13.95%-185.67%42.15%59.70%36.70%-3,782.64%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙